RESUMEN
Tumor barrier function in carcinoma represents a major challenge to treatment and is therefore an attractive target for increasing drug delivery. Variables related to tumor barrier include aberrant blood vessels, high interstitial fluid pressure, and the composition and structure of the extracellular matrix. One of the proteins associated with dense extracellular matrices is fibromodulin, a collagen fibrillogenesis modulator expressed in tumor stroma but scarce in normal loose connective tissues. Here, we investigated the effects of fibromodulin on stroma ECM in a syngeneic murine colon carcinoma model. We show that fibromodulin deficiency decreased collagen fibril thickness but glycosaminoglycan content and composition were unchanged. Furthermore, vascular density, pericyte coverage and macrophage amount were unaffected. Fibromodulin can therefore be a unique effector of dense collagen matrix assembly in tumor stroma and, without affecting other major matrix components or the cellular composition, can function as a main agent in tumor barrier function.
Asunto(s)
Colágeno/metabolismo , Neoplasias del Colon/metabolismo , Modelos Animales de Enfermedad , Fibromodulina/deficiencia , Glicosaminoglicanos/metabolismo , Animales , Línea Celular Tumoral , Neoplasias del Colon/patología , Fibromodulina/genética , Ratones , Ratones Endogámicos C57BLRESUMEN
A typical obstacle to cancer therapy is the limited distribution of low molecular weight anticancer drugs within the carcinoma tissue. In experimental carcinoma, imatinib (STI571) increases efficacy of synchronized chemotherapy, reduces tumor interstitial fluid pressure, and increases interstitial fluid volume. STI571 also increases the water-perfusable fraction in metastases from human colorectal adenocarcinomas. Because the mechanism(s) behind these effects have not been fully elucidated, we investigated the hypothesis that STI571 alters specific properties of the stromal extracellular matrix. We analyzed STI571-treated human colorectal KAT-4/HT-29 experimental carcinomas, known to have a well-developed stromal compartment, for solute exchange and glycosaminoglycan content, as well as collagen content, structure, and synthesis. MRI of STI571-treated KAT-4/HT-29 experimental carcinomas showed a significantly increased efficacy in dynamic exchanges of solutes between tumor interstitium and blood. This effect was paralleled by a distinct change of the stromal collagen network architecture, manifested by a decreased average collagen fibril diameter, and increased collagen turnover. The glycosaminoglycan content was unchanged. Furthermore, the apparent effects on the stromal cellular composition were limited to a reduction in an NG2-positive stromal cell population. The current data support the hypothesis that the collagen network architecture influences the dynamic exchanges of solutes between blood and carcinoma tissue. It is conceivable that STI571 reprograms distinct nonvascular stromal cells to produce a looser extracellular matrix, ultimately improving transport characteristics for traditional chemotherapeutic agents. Mol Cancer Ther; 15(10); 2455-64. ©2016 AACR.
Asunto(s)
Antineoplásicos/farmacología , Carcinoma/metabolismo , Colágeno/metabolismo , Líquido Extracelular/metabolismo , Mesilato de Imatinib/farmacología , Agregado de Proteínas , Inhibidores de Proteínas Quinasas/farmacología , Animales , Carcinoma/tratamiento farmacológico , Carcinoma/patología , Línea Celular Tumoral , Modelos Animales de Enfermedad , Células Endoteliales/metabolismo , Femenino , Humanos , Inmunohistoquímica , Ratones , Pericitos/efectos de los fármacos , Pericitos/metabolismo , Células del Estroma/metabolismo , Ensayos Antitumor por Modelo de XenoinjertoRESUMEN
BACKGROUND: Dermatan sulfate (DS) is a highly sulfated polysaccharide with a variety of biological functions in extracellular matrix organization and processes such as tumorigenesis and wound healing. A distinct feature of DS is the presence of iduronic acid, produced by the two enzymes, DS-epimerase 1 and 2, which are encoded by Dse and Dsel, respectively. METHODS: We have previously shown that Dse knockout (KO) mice in a mixed C57BL/6-129/SvJ background have an altered collagen matrix structure in skin. In the current work we studied Dse KO mice in a pure NFR genetic background. RESULTS: Dse KO embryos and newborns had kinked tails and histological staining revealed significantly thicker epidermal layers in Dse KO mice when compared with heterozygote (Het) or wild-type (WT) littermates. Immunochemical analysis of the epidermal layers in newborn pups showed increased expression of keratin 5 in the basal layer and keratin 1 in the spinous layer. In addition, we observed an abdominal wall defect with herniated intestines in 16% of the Dse KO embryos. Other, less frequent, developmental defects were exencephaly and spina bifida. CONCLUSION: We conclude that the combination of defective collagen structure in the dermis and imbalanced keratinocyte maturation could be responsible for the observed developmental defects in Dse KO mice. In addition, we propose that Dse KO mice could be used as a model in pathogenetic studies of human fetal abdominal wall defects.
Asunto(s)
Pared Abdominal/anomalías , Carbohidrato Epimerasas/genética , Dermis/metabolismo , Hernia Abdominal/genética , Queratinocitos/metabolismo , Animales , Carbohidrato Epimerasas/deficiencia , Dermatán Sulfato/metabolismo , Dermis/patología , Modelos Animales de Enfermedad , Embrión de Mamíferos , Expresión Génica , Hernia Abdominal/complicaciones , Hernia Abdominal/patología , Humanos , Queratina-1/genética , Queratina-1/metabolismo , Queratina-15/genética , Queratina-15/metabolismo , Queratinocitos/patología , Ratones , Ratones Noqueados , Defectos del Tubo Neural/complicaciones , Defectos del Tubo Neural/genética , Defectos del Tubo Neural/patología , Disrafia Espinal/complicaciones , Disrafia Espinal/genética , Disrafia Espinal/patologíaRESUMEN
The controlled assembly of collagen monomers into fibrils, with accompanying intermolecular cross-linking by lysyl oxidase-mediated bonds, is vital to the structural and mechanical integrity of connective tissues. This process is influenced by collagen-associated proteins, including small leucine-rich proteins (SLRPs), but the regulatory mechanisms are not well understood. Deficiency in fibromodulin, an SLRP, causes abnormal collagen fibril ultrastructure and decreased mechanical strength in mouse tendons. In this study, fibromodulin deficiency rendered tendon collagen more resistant to nonproteolytic extraction. The collagen had an increased and altered cross-linking pattern at an early stage of fibril formation. Collagen extracts contained a higher proportion of stably cross-linked α1(I) chains as a result of their C-telopeptide lysines being more completely oxidized to aldehydes. The findings suggest that fibromodulin selectively affects the extent and pattern of lysyl oxidase-mediated collagen cross-linking by sterically hindering access of the enzyme to telopeptides, presumably through binding to the collagen. Such activity implies a broader role for SLRP family members in regulating collagen cross-linking placement and quantity.
Asunto(s)
Colágeno Tipo I/química , Proteínas de la Matriz Extracelular/deficiencia , Péptidos/química , Proteoglicanos/deficiencia , Tendones/metabolismo , Aldehídos/metabolismo , Secuencia de Aminoácidos , Animales , Colágeno Tipo I/metabolismo , Fibromodulina , Ratones , Modelos Moleculares , Datos de Secuencia Molecular , Péptidos/metabolismo , Estructura Terciaria de Proteína , Proteína-Lisina 6-Oxidasa/metabolismoRESUMEN
The presence of iduronic acid in chondroitin/dermatan sulfate changes the properties of the polysaccharides because it generates a more flexible chain with increased binding potentials. Iduronic acid in chondroitin/dermatan sulfate influences multiple cellular properties, such as migration, proliferation, differentiation, angiogenesis and the regulation of cytokine/growth factor activities. Under pathological conditions such as wound healing, inflammation and cancer, iduronic acid has diverse regulatory functions. Iduronic acid is formed by two epimerases (i.e. dermatan sulfate epimerase 1 and 2) that have different tissue distribution and properties. The role of iduronic acid in chondroitin/dermatan sulfate is highlighted by the vast changes in connective tissue features in patients with a new type of Ehler-Danlos syndrome: adducted thumb-clubfoot syndrome. Future research aims to understand the roles of the two epimerases and their interplay with the sulfotransferases involved in chondroitin sulfate/dermatan sulfate biosynthesis. Furthermore, a better definition of chondroitin/dermatan sulfate functions using different knockout models is needed. In this review, we focus on the two enzymes responsible for iduronic acid formation, as well as the role of iduronic acid in health and disease.
Asunto(s)
Antígenos de Neoplasias/metabolismo , Carbohidrato Epimerasas/metabolismo , Sulfatos de Condroitina/metabolismo , Proteínas de Unión al ADN/metabolismo , Dermatán Sulfato/metabolismo , Ácido Idurónico/metabolismo , Proteínas de Neoplasias/metabolismo , Secuencias de Aminoácidos , Animales , Antígenos de Neoplasias/genética , Carbohidrato Epimerasas/genética , Carcinoma de Células Escamosas/metabolismo , Carcinoma de Células Escamosas/patología , Movimiento Celular , Proteínas de Unión al ADN/genética , Dermatán Sulfato/biosíntesis , Síndrome de Ehlers-Danlos/patología , Matriz Extracelular/metabolismo , Anomalías del Ojo , Deformidades Congénitas del Pie/patología , Deformidades Congénitas de la Mano/patología , Humanos , Inestabilidad de la Articulación/congénito , Conformación Molecular , Proteínas de Neoplasias/genética , Anomalías Cutáneas , Células Madre/metabolismo , Sulfotransferasas/genética , Sulfotransferasas/metabolismo , Pulgar/anomalías , Pulgar/patologíaRESUMEN
OBJECTIVE: The aim of this study was to analyze how an altered collagen structure affects development of atherosclerotic plaques. METHODS AND RESULTS: Fibromodulin-null mice develop an abnormal collagen fibril structure. In apolipoprotein E (ApoE)-null and ApoE/fibromodulin-null mice, a shear stress-modifying carotid artery cast induced formation of atherosclerotic plaques of different phenotypes; inflammatory in low-shear stress regions and fibrous in oscillatory shear stress regions. Electron microscopy showed that collagen fibrils were thicker and more heterogeneous in oscillatory shear stress lesions from ApoE/fibromodulin-null mice. Low-shear stress lesions were smaller in ApoE/fibromodulin-null mice and contained less lipids. Total plaque burden in aortas stained en face with Oil Red O, as well as lipid accumulation in aortic root lesions, was also decreased in ApoE/fibromodulin-null mice. In addition, lipid accumulation in RAW264.7 macrophages cultured on fibromodulin-deficient extracellular matrix was decreased, whereas levels of interleukin-6 and -10 were increased. Our results show that an abnormal plaque collagen fibril structure can influence atherosclerotic plaque development. CONCLUSIONS: The present findings suggest a more complex role for collagen in plaque stability than previously anticipated, in that it may promote lipid-accumulation and inflammation at the same time as it provides mechanical stability.
Asunto(s)
Aorta/metabolismo , Enfermedades de la Aorta/metabolismo , Apolipoproteínas E/deficiencia , Aterosclerosis/metabolismo , Arterias Carótidas/metabolismo , Enfermedades de las Arterias Carótidas/metabolismo , Proteínas de la Matriz Extracelular/deficiencia , Lipoproteínas LDL/metabolismo , Proteoglicanos/deficiencia , Animales , Aorta/inmunología , Aorta/fisiopatología , Aorta/ultraestructura , Enfermedades de la Aorta/genética , Enfermedades de la Aorta/inmunología , Enfermedades de la Aorta/patología , Enfermedades de la Aorta/fisiopatología , Enfermedades de la Aorta/prevención & control , Apolipoproteínas E/genética , Aterosclerosis/genética , Aterosclerosis/inmunología , Aterosclerosis/patología , Aterosclerosis/fisiopatología , Aterosclerosis/prevención & control , Arterias Carótidas/inmunología , Arterias Carótidas/fisiopatología , Arterias Carótidas/ultraestructura , Enfermedades de las Arterias Carótidas/genética , Enfermedades de las Arterias Carótidas/inmunología , Enfermedades de las Arterias Carótidas/patología , Enfermedades de las Arterias Carótidas/fisiopatología , Enfermedades de las Arterias Carótidas/prevención & control , Línea Celular , Proliferación Celular , Modelos Animales de Enfermedad , Regulación hacia Abajo , Proteínas de la Matriz Extracelular/genética , Colágenos Fibrilares/metabolismo , Colágenos Fibrilares/ultraestructura , Fibromodulina , Genotipo , Interleucina-10/metabolismo , Interleucina-6/metabolismo , Macrófagos/inmunología , Macrófagos/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Microscopía Electrónica de Transmisión , Fenotipo , Placa Aterosclerótica , Proteoglicanos/genética , Flujo Sanguíneo Regional , Estrés MecánicoRESUMEN
Stroma properties affect carcinoma physiology and direct malignant cell development. Here we present data showing that α(V)ß(3) expressed by stromal cells is involved in the control of interstitial fluid pressure (IFP), extracellular volume (ECV) and collagen scaffold architecture in experimental murine carcinoma. IFP was elevated and ECV lowered in syngeneic CT26 colon and LM3 mammary carcinomas grown in integrin ß(3)-deficient compared to wild-type BALB/c mice. Integrin ß(3)-deficiency had no effect on carcinoma growth rate or on vascular morphology and function. Analyses by electron microscopy of carcinomas from integrin ß(3)-deficient mice revealed a coarser and denser collagen network compared to carcinomas in wild-type littermates. Collagen fibers were built from heterogeneous and thicker collagen fibrils in carcinomas from integrin ß(3)-deficient mice. The fibrotic extracellular matrix (ECM) did not correlate with increased macrophage infiltration in integrin ß(3)-deficient mice bearing CT26 tumors, indicating that the fibrotic phenotype was not mediated by increased inflammation. In conclusion, we report that integrin ß(3)-deficiency in tumor stroma led to an elevated IFP and lowered ECV that correlated with a more fibrotic ECM, underlining the role of the collagen network for carcinoma physiology.
Asunto(s)
Carcinoma/metabolismo , Fibrosis/patología , Regulación Neoplásica de la Expresión Génica , Integrina beta3/genética , Animales , Línea Celular Tumoral , Colágeno/metabolismo , Líquido Extracelular , Femenino , Hidroxiprolina/metabolismo , Integrina alfaVbeta3/metabolismo , Masculino , Ratones , Ratones Endogámicos BALB C , Trasplante de Neoplasias , Fenotipo , PresiónRESUMEN
Dermatan sulfate epimerase 2 (DS-epi2), together with its homolog DS-epi1, transform glucuronic acid into iduronic acid in DS polysaccharide chains. Iduronic acid gives DS increased chain flexibility and promotes protein binding. DS-epi2 is ubiquitously expressed and is the predominant epimerase in the brain. Here, we report the generation and initial characterization of DS-epi2 null mice. DS-epi2-deficient mice showed no anatomical, histological or morphological abnormalities. The body weights and lengths of mutated and wild-type littermates were indistinguishable. They were fertile and had a normal lifespan. Chondroitin sulfate (CS)/DS isolated from the newborn mutated mouse brains had a 38% reduction in iduronic acid compared with wild-type littermates, and compositional analysis revealed a decrease in 4-O-sulfate and an increase in 6-O-sulfate containing structures. Despite the reduction in iduronic acid, the adult DS-epi2-/- brain showed normal extracellular matrix features by immunohistological stainings. We conclude that DS-epi1 compensates in vivo for the loss of DS-epi2. These results extend previous findings of the functional redundancy of brain extracellular matrix components.
Asunto(s)
Encéfalo/crecimiento & desarrollo , Carbohidrato Epimerasas/deficiencia , Dermatán Sulfato/metabolismo , Animales , Encéfalo/citología , Encéfalo/enzimología , Conformación de Carbohidratos , Carbohidrato Epimerasas/genética , Células Cultivadas , Disacáridos/metabolismo , Matriz Extracelular/metabolismo , Femenino , Técnicas de Inactivación de Genes , Ácido Idurónico/metabolismo , Riñón/metabolismo , Masculino , Ratones , Ratones de la Cepa 129 , Ratones Endogámicos C57BL , Ratones Transgénicos , Sulfatos/metabolismoRESUMEN
Fibromodulin regulates collagen fibrillogenesis, but its existence/role(s) in the cornea is controversial. We hypothesize that fibromodulin regulates fibrillogenesis during postnatal development of the anterior eye. Fibromodulin is weakly expressed in the limbus at post-natal day (P) 4, increases and extends into the central cornea at P14, becomes restricted to the limbus at P30, and decreases at P60. This differential spatial and temporal expression of fibromodulin is coordinated with emmetropization; the developmental increase in axial length and globe size. Genetic analysis demonstrated that fibromodulin regulates fibrillogenesis in a region-specific manner. At the limbus, fibromodulin is dominant in regulating fibril growth during postnatal development. In the posterior peripheral cornea, cooperative interactions of fibromodulin and lumican regulate fibrillogenesis. These data indicate that fibromodulin plays important roles in the regulation of region-specific fibrillogenesis required for the integration of the corneal and scleral matrices and sulcus development required for establishment of the visual axis.
Asunto(s)
Colágeno/metabolismo , Córnea/embriología , Proteínas de la Matriz Extracelular/metabolismo , Regulación del Desarrollo de la Expresión Génica , Proteoglicanos/metabolismo , Animales , Proteoglicanos Tipo Condroitín Sulfato/biosíntesis , Córnea/metabolismo , Matriz Extracelular/metabolismo , Proteínas de la Matriz Extracelular/biosíntesis , Fibromodulina , Sulfato de Queratano/biosíntesis , Lumican , Ratones , Ratones Transgénicos , Microscopía Electrónica de Transmisión/métodos , Modelos Genéticos , Proteoglicanos/biosíntesis , ARN Mensajero/metabolismo , Tendones/metabolismo , Factores de Tiempo , Visión OcularRESUMEN
Small leucine-rich proteoglycans/proteins (SLRPs) are associated with collagen fibril formation, and therefore important for the proper formation of extracellular matrices. SLRPs are differentially expressed in tissues and during pathological conditions, contributing to the development of connective tissue properties. The binding of SLRPs to collagens have recently been characterized, and may give some clues to the significance of these interactions. In this mini review, we summarize published work in this field, and propose several mechanisms for how SLRPs can control collagen matrix structure and function. SLRPs appear to influence collagen cross-linking patterns. We also propose that the SLRP-collagen interactions can assist in the process of juxtaposing the collagen monomers by steric hindrance or by directly connecting two collagen monomers during the fibril growth.
Asunto(s)
Colágeno/metabolismo , Matriz Extracelular/metabolismo , Leucina/análisis , Proteínas/metabolismo , Proteoglicanos , Animales , Colágeno/análisis , Colágeno/genética , Tejido Conectivo/metabolismo , Matriz Extracelular/química , Matriz Extracelular/genética , Leucina/genética , Leucina/metabolismo , Ratones , Proteínas/análisis , Proteínas/genética , Proteoglicanos/química , Proteoglicanos/genética , Proteoglicanos/metabolismoRESUMEN
The temporomandibular joint is critical for jaw movements and allows for mastication, digestion of food, and speech. Temporomandibular joint osteoarthritis is a degenerative disease that is marked by permanent cartilage destruction and loss of extracellular matrix (ECM). To understand how the ECM regulates mandibular condylar chondrocyte (MCC) differentiation and function, we used a genetic mouse model of temporomandibular joint osteoarthritis that is deficient in two ECM proteins, biglycan and fibromodulin (Bgn(-/0)Fmod(-/-)). Given the unavailability of cell lines, we first isolated primary MCCs and found that they were phenotypically unique from hyaline articular chondrocytes isolated from the knee joint. Using Bgn(-/0) Fmod(-/-) MCCs, we discovered the early basis for temporomandibular joint osteoarthritis arises from abnormal and accelerated chondrogenesis. Transforming growth factor (TGF)-beta1 is a growth factor that is critical for chondrogenesis and binds to both biglycan and fibromodulin. Our studies revealed the sequestration of TGF-beta1 was decreased within the ECM of Bgn(-/0) Fmod(-/-) MCCs, leading to overactive TGF-beta1 signal transduction. Using an explant culture system, we found that overactive TGF-beta1 signals induced chondrogenesis and ECM turnover in this model. We demonstrated for the first time a comprehensive study revealing the importance of the ECM in maintaining the mandibular condylar cartilage integrity and identified biglycan and fibromodulin as novel key players in regulating chondrogenesis and ECM turnover during temoporomandibular joint osteoarthritis pathology.
Asunto(s)
Condrogénesis/genética , Proteínas de la Matriz Extracelular/fisiología , Matriz Extracelular/metabolismo , Osteoartritis/genética , Proteoglicanos/fisiología , Trastornos de la Articulación Temporomandibular/genética , Articulación Temporomandibular/patología , Animales , Biglicano , Diferenciación Celular/genética , Proliferación Celular , Células Cultivadas , Condrocitos/metabolismo , Condrocitos/patología , Matriz Extracelular/genética , Matriz Extracelular/patología , Proteínas de la Matriz Extracelular/genética , Proteínas de la Matriz Extracelular/metabolismo , Femenino , Fibromodulina , Masculino , Cóndilo Mandibular/metabolismo , Cóndilo Mandibular/patología , Ratones , Ratones Noqueados , Osteoartritis/metabolismo , Osteoartritis/patología , Proteoglicanos/genética , Proteoglicanos/metabolismo , Articulación Temporomandibular/metabolismo , Trastornos de la Articulación Temporomandibular/metabolismo , Trastornos de la Articulación Temporomandibular/patologíaRESUMEN
Dermatan sulfate epimerase 1 (DS-epi1) and DS-epi2 convert glucuronic acid to iduronic acid in chondroitin/dermatan sulfate biosynthesis. Here we report on the generation of DS-epi1-null mice and the resulting alterations in the chondroitin/dermatan polysaccharide chains. The numbers of long blocks of adjacent iduronic acids are greatly decreased in skin decorin and biglycan chondroitin/dermatan sulfate, along with a parallel decrease in iduronic-2-O-sulfated-galactosamine-4-O-sulfated structures. Both iduronic acid blocks and iduronic acids surrounded by glucuronic acids are also decreased in versican-derived chains. DS-epi1-deficient mice are smaller than their wild-type littermates but otherwise have no gross macroscopic alterations. The lack of DS-epi1 affects the chondroitin/dermatan sulfate in many proteoglycans, and the consequences for skin collagen structure were initially analyzed. We found that the skin collagen architecture was altered, and electron microscopy showed that the DS-epi1-null fibrils have a larger diameter than the wild-type fibrils. The altered chondroitin/dermatan sulfate chains carried by decorin in skin are likely to affect collagen fibril formation and reduce the tensile strength of DS-epi1-null skin.
Asunto(s)
Carbohidrato Epimerasas/metabolismo , Colágeno/metabolismo , Dermatán Sulfato/metabolismo , Ácido Idurónico/metabolismo , Piel/metabolismo , Animales , Carbohidrato Epimerasas/genética , Colágeno/ultraestructura , Decorina , Dermatán Sulfato/genética , Proteínas de la Matriz Extracelular/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Microscopía Electrónica de Transmisión , Proteoglicanos/metabolismo , Piel/enzimología , Piel/ultraestructuraRESUMEN
The interactions of the ECM (extracellular matrix) protein asporin with ECM components have previously not been investigated. Here, we show that asporin binds collagen type I. This binding is inhibited by recombinant asporin fragment LRR (leucine-rich repeat) 10-12 and by full-length decorin, but not by biglycan. We demonstrate that the polyaspartate domain binds calcium and regulates hydroxyapatite formation in vitro. In the presence of asporin, the number of collagen nodules, and mRNA of osteoblastic markers Osterix and Runx2, were increased. Moreover, decorin or the collagen-binding asporin fragment LRR 10-12 inhibited the pro-osteoblastic activity of full-length asporin. Our results suggest that asporin and decorin compete for binding to collagen and that the polyaspartate in asporin directly regulates collagen mineralization. Therefore asporin has a role in osteoblast-driven collagen biomineralization activity. We also show that asporin can be expressed in Escherichia coli (Rosetta-gami) with correctly positioned cysteine bridges, and a similar system can possibly be used for the expression of other SLRPs (small LRR proteoglycans/proteins).
Asunto(s)
Calcificación Fisiológica , Calcio/metabolismo , Colágeno/metabolismo , Proteínas de la Matriz Extracelular/metabolismo , Proteínas de la Matriz Extracelular/fisiología , Osteoblastos/metabolismo , Proteoglicanos/metabolismo , Secuencia de Aminoácidos , Unión Competitiva/fisiología , Calcificación Fisiológica/fisiología , Células Cultivadas , Cisteína/metabolismo , Decorina , Disulfuros/química , Disulfuros/metabolismo , Proteínas de la Matriz Extracelular/química , Colágenos Fibrilares/metabolismo , Humanos , Unión ProteicaRESUMEN
Lumican and fibromodulin compete for collagen type I binding in vitro, and fibromodulin-deficient mice have 4-fold more lumican in tendons. These observations indicate that homologous sequences in lumican and fibromodulin bind to collagen type I. Here, we demonstrate that lumican binding to collagen type I is mediated mainly by Asp-213 in leucine-rich repeat (LRR) 7. The mutation D213N in lumican impairs interaction with collagen, and the lumican fragment spanning LRRs 5-7 is an efficient inhibitor of collagen binding. Also, the lumican LRR 7 sequence-based synthetic peptide CYLDNNKC inhibits the binding to collagen. Homologous collagen-binding site in fibromodulin, located in LRRs 5-7, inhibits the binding of lumican to collagen, and the mutation E251Q in this fibromodulin fragment does not inhibit the lumican-collagen binding. Lumican, but not the D213N mutation, lowers the melting point and affects the packing of collagen fibrils.
Asunto(s)
Proteoglicanos Tipo Condroitín Sulfato/química , Colágeno Tipo I/química , Proteínas de la Matriz Extracelular/química , Sulfato de Queratano/química , Péptidos/química , Proteoglicanos/química , Sustitución de Aminoácidos , Animales , Sitios de Unión/fisiología , Proteoglicanos Tipo Condroitín Sulfato/genética , Proteoglicanos Tipo Condroitín Sulfato/metabolismo , Colágeno Tipo I/genética , Colágeno Tipo I/metabolismo , Proteínas de la Matriz Extracelular/genética , Proteínas de la Matriz Extracelular/metabolismo , Fibromodulina , Humanos , Sulfato de Queratano/genética , Sulfato de Queratano/metabolismo , Lumican , Ratones , Mutación Missense , Péptidos/genética , Péptidos/metabolismo , Unión Proteica/fisiología , Proteoglicanos/genética , Proteoglicanos/metabolismo , Homología de Secuencia de AminoácidoRESUMEN
INTRODUCTION: Cartilage oligomeric matrix protein (COMP) is a homopentameric protein in cartilage. The development of arthritis, like collagen-induced arthritis (CIA), involves cartilage as a target tissue. We have investigated the development of CIA in COMP-deficient mice. METHODS: COMP-deficient mice in the 129/Sv background were backcrossed for 10 generations against B10.Q mice, which are susceptible to chronic CIA. COMP-deficient and wild-type mice were tested for onset, incidence, and severity of arthritis in both the collagen and collagen antibody-induced arthritis models. Serum anti-collagen II and anti-COMP antibodies as well as serum COMP levels in arthritic and wild-type mice were measured by enzyme-linked immunosorbent assay. RESULTS: COMP-deficient mice showed a significant early onset and increase in the severity of CIA in the chronic phase, whereas collagen II-antibody titers were similar in COMP-deficient and wild-type controls. COMP antibodies were not found in wild-type mice. Finally, COMP-deficient and wild-type mice responded similarly to collagen antibody-induced arthritis, indicating no difference in how collagen II antibodies interact with COMP-deficient cartilage during the initial stages of arthritis. CONCLUSIONS: COMP deficiency enhances the early onset and development of chronic arthritis but does not affect collagen II autoimmunity. These findings accentuate the importance of COMP in cartilage stability.
Asunto(s)
Artritis Experimental/inmunología , Proteínas de la Matriz Extracelular/deficiencia , Glicoproteínas/deficiencia , Edad de Inicio , Animales , Artritis Experimental/genética , Artritis Experimental/metabolismo , Cartílago Articular/inmunología , Cartílago Articular/patología , Enfermedad Crónica , Colágeno Tipo II/inmunología , Proteínas de la Matriz Extracelular/genética , Proteínas de la Matriz Extracelular/inmunología , Femenino , Glicoproteínas/genética , Glicoproteínas/inmunología , Mediadores de Inflamación/inmunología , Mediadores de Inflamación/metabolismo , Masculino , Proteínas Matrilinas , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos DBA , Ratones Noqueados , Ratas , Índice de Severidad de la EnfermedadAsunto(s)
Sustancia Propia , Ingeniería de Tejidos , Andamios del Tejido , Colágeno Tipo I , Geles , MagnetismoRESUMEN
Research on the biology of the tumor stroma has the potential to lead to development of more effective treatment regimes enhancing the efficacy of drug-based treatment of solid malignancies. Tumor stroma is characterized by distorted blood vessels and activated connective tissue cells producing a collagen-rich matrix, which is accompanied by elevated interstitial fluid pressure (IFP), indicating a transport barrier between tumor tissue and blood. Here, we show that the collagen-binding proteoglycan fibromodulin controls stroma structure and fluid balance in experimental carcinoma. Gene ablation or inhibition of expression by anti-inflammatory agents showed that fibromodulin promoted the formation of a dense stroma and an elevated IFP. Fibromodulin-deficiency did not affect vasculature but increased the extracellular fluid volume and lowered IFP. Our data suggest that fibromodulin controls stroma matrix structure that in turn modulates fluid convection inside and out of the stroma. This finding is particularly important in relation to the demonstration that targeted modulations of the fluid balance in carcinoma can increase the response to cancer therapeutic agents.
Asunto(s)
Colágeno/metabolismo , Proteínas de la Matriz Extracelular/metabolismo , Proteoglicanos/metabolismo , Animales , Carcinoma/irrigación sanguínea , Carcinoma/metabolismo , Carcinoma/patología , Líquido Extracelular/fisiología , Matriz Extracelular/patología , Matriz Extracelular/ultraestructura , Proteínas de la Matriz Extracelular/deficiencia , Proteínas de la Matriz Extracelular/genética , Fibromodulina , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Proteoglicanos/deficiencia , Proteoglicanos/genética , Neoplasias de la Tiroides/irrigación sanguínea , Neoplasias de la Tiroides/metabolismo , Neoplasias de la Tiroides/patologíaRESUMEN
Fibromodulin belongs to the small leucine-rich repeat proteoglycan family, interacts with collagen type I, and controls collagen fibrillogenesis and assembly. Here, we show that a major fibromodulin-binding site for collagen type I is located in leucine-rich repeat 11 in the C terminus of the leucine-rich repeat domain. We identified Glu-353 and Lys-355 in repeat 11 as essential for binding, and the synthetic peptide RLDGNEIKR, including Glu-353 and Lys-355, inhibits the binding of fibromodulin to collagen in vitro. Fibromodulin and lumican compete for the same binding region on collagen, and fibromodulin can inhibit the binding of lumican to collagen type I. However, the peptide RLDGNEIKR does not inhibit the binding of lumican to collagen, suggesting separate but closely situated fibromodulin- and lumican-binding sites in collagen. The collagen-binding Glu-353 and Lys-355 residues in fibromodulin are exposed on the exterior of the beta-sheet-loop structure of the leucine-rich repeat, which resembles the location of interacting residues in other leucine-rich repeat proteins, e.g. decorin.
Asunto(s)
Colágeno Tipo I/química , Proteínas de la Matriz Extracelular/química , Proteínas/química , Proteoglicanos/química , Sitios de Unión , Proteoglicanos Tipo Condroitín Sulfato/química , Proteoglicanos Tipo Condroitín Sulfato/metabolismo , Colágeno Tipo I/metabolismo , Proteínas de la Matriz Extracelular/metabolismo , Fibromodulina , Ácido Glutámico , Humanos , Sulfato de Queratano/química , Sulfato de Queratano/metabolismo , Proteínas Repetidas Ricas en Leucina , Lumican , Lisina , Mutagénesis Sitio-Dirigida , Estructura Secundaria de Proteína , Estructura Terciaria de Proteína , Proteoglicanos/metabolismoRESUMEN
The creation of 3D scaffolds that mimic the structure of physiological tissue required for normal cell function is a major bioengineering challenge. For corneal stroma reconstruction this necessitates the creation of a stroma-like scaffold consisting of a stack of orthogonally disposed sheets of aligned collagen fibrils. This study demonstrates that such a scaffold can be built up using magnetic alignment. By allowing neutralized acid-soluble type I collagen to gel in a horizontal magnetic field (7 T) and by combining a series of gelation-rotation-gelation cycles, a scaffold of orthogonal lamellae composed of aligned collagen fibrils has been formed. Although initially dilute, the gels can be concentrated without noticeable loss in orientation. The gels are translucent but their transparency can be greatly improved by the addition of proteoglycans to the gel-forming solution. Keratocytes align by contact guidance along the direction of collagen fibrils and respect the orthogonal design of the collagen template as they penetrate into the bulk of the 3D matrix. The scaffold is a significant step towards the creation of a corneal substitute with properties resembling those of native corneal stroma.
Asunto(s)
Colágeno/química , Sustancia Propia/cirugía , Regeneración Tisular Dirigida/métodos , Queratinocitos/química , Queratinocitos/citología , Procedimientos Quirúrgicos Oftalmológicos/métodos , Ingeniería de Tejidos/métodos , Materiales Biocompatibles/química , Proliferación Celular , Colágeno/ultraestructura , Sustancia Propia/citología , Queratinocitos/trasplante , Magnetismo , Conformación ProteicaRESUMEN
Decorin belongs to the small leucine-rich repeat proteoglycan family, interacts with fibrillar collagens, and regulates the assembly, structure, and biomechanical properties of connective tissues. The decorin-collagen type I-binding region is located in leucine-rich repeats 5-6. Site-directed mutagenesis of this 54-residue-long collagen-binding sequence identifies Arg-207 and Asp-210 in leucine-rich repeat 6 as crucial for the binding to collagen. The synthetic peptide SYIRIADTNIT, which includes Arg-207 and Asp-210, inhibits the binding of full-length recombinant decorin to collagen in vitro. These collagen-binding amino acids are exposed on the exterior of the beta-sheet-loop structure of the leucine-rich repeat. This resembles the location of interacting residues in other leucine-rich repeat proteins.